Pancreatic Surgery Unit, Humanitas Clinical and Research Center-IRCCS, 20089 Rozzano, Italy.
Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20090 Milan, Italy.
Curr Oncol. 2023 Jul 22;30(7):6996-7006. doi: 10.3390/curroncol30070507.
There are different cancers in the peri-ampullary region, including pancreatic ductal adenocarcinoma (PDAC), duodenum cancers (DCs), and ampullary adenocarcinoma (AAC). Here, significant morphological-molecular characterizations should be necessary for the distinction of primary tumours and classifications of their subtypes of cancers. The sub classification of AACs might include up to five different variants, according to different points of view, concerning the prevalence of the two more-cellular components found in the ampulla. In particular, regarding the AACs, the most important subtypes are represented by the intestinal (INT) and the pancreato-biliary (PB) ones. The subtyping of AACs is essential for diagnosis, and their identifications have been impacting clinical management responses to treatments and overall survival (os) after surgery. Pb is associated with a worse clinical outcome. Otherwise, the criteria, through which are possible to attribute its subtype classification, are not well established. A triage of immune markers represented by CK7, CK20, and CDX-2 seem to represent the best compromise in order to split the cohort of AAC patients in the INT and PB groups. The test of choice for the sub-classification of AACs is represented by the immuno-histochemical approach, in which its molecular classification acquires its diagnostic, predictive, and prognostic value for both the INT and PB patients.
在胰周区域有不同的癌症,包括胰腺导管腺癌(PDAC)、十二指肠癌(DC)和壶腹腺癌(AAC)。在这里,为了区分原发性肿瘤和癌症亚型的分类,应该进行显著的形态-分子特征描述。根据在壶腹发现的两种更具细胞成分的流行程度,AAC 的亚分类可能包括多达五个不同的变体,从不同的观点来看。特别是对于 AAC,最重要的亚型是肠型(INT)和胰胆管型(PB)。AAC 的亚型分类对于诊断很重要,它们的鉴定已经影响了对治疗和手术后总生存期(os)的临床管理反应。PB 与更差的临床结果相关。否则,还没有确定其亚型分类的标准。以 CK7、CK20 和 CDX-2 为代表的免疫标志物的分类似乎是将 AAC 患者分为 INT 和 PB 组的最佳折衷方案。AAC 亚型分类的首选方法是免疫组织化学方法,其分子分类在 INT 和 PB 患者中均具有诊断、预测和预后价值。